Soleno Therapeutics, Inc. | 15,083 followers on LinkedIn. We believe in science, advocacy & community, striving to make a real impact for those affected by rare diseases. | At Soleno Therapeutics, we believe in the power of science, advocacy, and community. We are honored to stand alongside the Prader-Willi syndrome (PWS) community and are committed to making a meaningful difference in the lives of those impacted by rare diseases. The first and only therapy for the treatment of hyperphagia in #PraderWilliSyndrome received FDA-approval in March 2025.